Conference abstractPublished 31 Jul 2021
MD simulations of estrogen receptors (ER) and docking analysis of DPN analogues reveal insights about subtype-receptor selectivity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Estrogen (17-estradiol) is essential for normal growth and differentiation in the mammary gland. In the last three decades previous investigations have revealed that estrogen receptor alpha (ERα) plays a critical role in breast cancer. More recently, observations regarding the widespread expression of ERβ-like proteins in normal and neoplastic mammary tissues have suggested that ERβ is involved in the mentioned pathology. Therefore, design of new drugs both steroidal and nonsteroidal that target ERβ represents a therapeutical promise to treat several diseases. In this work, we have proposed a new set of compounds that target effectively the estrogen receptors, and particularly the ERβ. They were designed based on the chemical structure of the ERβ-selective agonist diarylpropionitrile (DPN), then, these potential ligands were submitted in silico ADMET (absorption, distribution, metabolism, excretion, toxicity), from such analysis we could select the ones that showed better properties and they were used for docking studies on ERα and ERβ, employing snapshots at 0 ns and 100 ns retrieved from Molecular Dynamics (MD) Simulations.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Computational Methods in Molecular Design
- SubjectGenetics & Molecular Biology
- SubjectMathematics & Statistics
- BylineArticles whose byline prints “Marlet Martinez”